Literature DB >> 12530415

Olanzapine treatment for patients with schizophrenia and cocaine abuse.

John Tsuang, Stephen R Marder, Amanda Han, Winnie Hsieh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12530415     DOI： 10.4088/jcp.v63n1214c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  6 in total

Review 1.  Pharmacotherapy for schizophrenia and co-occurring substance use disorders.

Authors:  Alan I Green
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

Review 2.  [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Authors:  T Wobrock; R D'Amelio; P Falkai
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

3.  The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use.

Authors:  Maju Mathew Koola; Heidi J Wehring; Deanna L Kelly
Journal:  J Dual Diagn       Date:  2012

Review 4.  Pharmacotherapy for schizophrenia and co-occurring substance use disorders.

Authors:  Douglas L Noordsy; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

5.  Psychoactive substance use among outpatients with severe mental illness: A comparative study.

Authors:  Oladipo A Sowunmi; Gbolagade Amoo; Peter O Onifade; Adegboyega Ogunwale; Emmanuel Babalola
Journal:  S Afr J Psychiatr       Date:  2019-09-30       Impact factor: 1.550

Review 6.  Antipsychotic medications for cocaine dependence.

Authors:  Blanca I Indave; Silvia Minozzi; Pier Paolo Pani; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.